I remember my first case of breast cancer to this day. She was a young woman of 33 and she was very upset at the prospect of losing her breast. Yes, in those days the inhuman operation of total mastectomy was still routine and the treatment of choice of the surgeon I was apprenticed to.… Read More »
Dramatic declines in HIV diagnoses in San Francisco have been attributed to testing, treatment and PrEP, but the declining Black population in the city is an unexamined factor, Dr Jade Pagkas-Bather of the University of Chicago and colleagues argue in the December issue of The Lancet HIV. There has been a 22% fall in San… Read More »
The United States could see “staggering” numbers of coronavirus deaths in the coming months as infection rates increase during the colder months, Dr. Scott Gottlieb told CNBC’s “Closing Bell” on Friday. There were 916 deaths from Covid-19 in the U.S. on Friday, according to data compiled by the Covid Tracking Project, an independent volunteer organization launched… Read More »
As one of the hottest markets in pharmaceuticals, immunology has become a murderers’ row of blockbuster drugs in recent years. But Bristol Myers Squibb has big hopes for a next-gen entry in Zeposia, and it’s angling for a foothold in ulcerative colitis to get the ball rolling. Zeposia helped 18.4% of ulcerative colitis patients reach clinical remission at… Read More »